-- Lurie Cancer Center Completes Dosing of First Patient with LIXTE’s LB-100 in Combination with GSK’s Immunotherapy Dostarlimab -- PASADENA,…
AlterDiag has signed a long-term strategic partnership agreement with the Institut Pasteur for the development of new single-domain antibodies-based rapid…
TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25…
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural…
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure…
WILMINGTON, N.C., Feb. 25, 2025 /PRNewswire/ -- Frontier Scientific Solutions, a temperature-controlled storage and transportation company exclusively serving the life…
CARY, N.C., Feb. 24, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of electronic batch record (EBR), manufacturing execution system (MES),…
Survey of 600+ Global Physicians Also Finds on Average Physicians Spend 22 Personal Hours a Month Learning New Healthcare Technology…
Survey of 600+ Global Physicians Also Finds on Average Physicians Spend 22 Personal Hours a Month Learning New Healthcare Technology…
PDUFA Date Set for October 20, 2025ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company…